Related Experiment Video
Updated: Jul 6, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Decreasing Primary Resection Rates for Crohn's Disease but Unchanged Re-Resection Rates: A Nationwide Danish
Anders Mark-Christensen1, Eskild Bendix Kristiansen2, Søren Laurberg3
1Department of Surgery, Odense University Hospital, Odense, Denmark.
Background & Aims:
The overarching goal in the medical management of Crohn's disease (CD) is to minimize disease burden for patients and prevent disease progression, where surgery often is necessary. The aim of this study was to examine rates of intestinal resections in CD over the past decades in a nationwide cohort.
Methods:
We identified all patients diagnosed with incident CD in Denmark from 1997 to 2021 from the Danish National Patient Registry. Cumulative incidences of intestinal resections and measures of disease severity were compared between calendar periods.
Results:
Among 18,303 patients with CD, 5-year resection rates decreased from 28% (95% confidence interval [CI], 26%-31%) in 1997 to 2000 to 16% (95% CI, 15%-17%) in 2013 to 2017. The proportion of elective surgeries increased from 60.2% to 67.7%, patients were operated earlier in their disease course (preoperative disease duration decreased from 1.9 years to 0.2 years), and more patients underwent laparoscopic procedures (increasing from 7.3% to 64.1%). There was no evidence of increased disease severity or complexity at first intestinal resection over time. From 1997 to 2017, 5-year rates of re-resections remained constant at 16-17%. Use of postoperative biologics within 12 months after first resection gradually increased to 30%, whereas the use of endoscopy within 12 months increased to 39% in the most recent period.
Conclusions:
Rates of primary resections in CD have decreased over the past decades without any evidence that this has been achieved at the expense of increased complexity at surgery. Re-resection rates have not changed in the past decades, suggesting a potential for improvement.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Crohn's Disease

